马来西亚单一三级中心COVID-19患者嗅觉功能障碍的纵向研究

IF 0.1 Q4 PEDIATRICS
Izzah Akashah, J. Saniasiaya, N. Prepageran, Carren Su-Lin Teh
{"title":"马来西亚单一三级中心COVID-19患者嗅觉功能障碍的纵向研究","authors":"Izzah Akashah, J. Saniasiaya, N. Prepageran, Carren Su-Lin Teh","doi":"10.15557/pimr.2022.0036","DOIUrl":null,"url":null,"abstract":"Aim: The aim of the study was to outline the longitudinal outcomes of olfactory dysfunction amongst patients with coronavirus disease 2019 (COVID-19) in a single tertiary centre in Malaysia. Materials and methods: Adults patients who tested positive for COVID-19 via reverse transcription-polymerase chain reaction and were admitted to Hospital Sungai Buloh, Malaysia, were recruited in this study. The patients completed a questionnaire via telephone interview comprising the following details: age, sex, ethnicity, comorbidities, general and otorhinolaryngological symptoms, and onset and duration of olfactory and gustatory dysfunction. The patients with persistent olfactory and gustatory dysfunction at the time of the initial interview were followed up every 3 to 5 days until resolution. Results: A total 185 patients were included in this study out of 378 patients contacted. Ninety patients reported olfactory dysfunction symptoms, with 59 of them complaining of anosmia. The mean age of the participants was 39.52 years (age range: 18–66 years). More than half of the patients with olfactory dysfunction had no comorbidities (55.56%). Of the 90 patients with olfactory dysfunction, 66 patients (73.3%), including 40 males and 26 females, regained their olfactory function completely within 2 weeks. The remaining 24 patients were contacted after 4, 8, and 12 weeks. Ten patients (11.1%) were found to have recovered their sense of smell after one month, while 5 patients (5.56%) recovered within 2 months, and 1 patient (1.11%) recovered in 3 months. Conclusion: Complete recovery was noted in 73% of the patients within a period of 2 weeks, whereas persistence of symptoms was noted in 6 patients (6.67%) after 3 months.","PeriodicalId":42380,"journal":{"name":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","volume":" ","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Longitudinal study of olfactory dysfunction among COVID-19 patients in a single tertiary centre in Malaysia\",\"authors\":\"Izzah Akashah, J. Saniasiaya, N. Prepageran, Carren Su-Lin Teh\",\"doi\":\"10.15557/pimr.2022.0036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The aim of the study was to outline the longitudinal outcomes of olfactory dysfunction amongst patients with coronavirus disease 2019 (COVID-19) in a single tertiary centre in Malaysia. Materials and methods: Adults patients who tested positive for COVID-19 via reverse transcription-polymerase chain reaction and were admitted to Hospital Sungai Buloh, Malaysia, were recruited in this study. The patients completed a questionnaire via telephone interview comprising the following details: age, sex, ethnicity, comorbidities, general and otorhinolaryngological symptoms, and onset and duration of olfactory and gustatory dysfunction. The patients with persistent olfactory and gustatory dysfunction at the time of the initial interview were followed up every 3 to 5 days until resolution. Results: A total 185 patients were included in this study out of 378 patients contacted. Ninety patients reported olfactory dysfunction symptoms, with 59 of them complaining of anosmia. The mean age of the participants was 39.52 years (age range: 18–66 years). More than half of the patients with olfactory dysfunction had no comorbidities (55.56%). Of the 90 patients with olfactory dysfunction, 66 patients (73.3%), including 40 males and 26 females, regained their olfactory function completely within 2 weeks. The remaining 24 patients were contacted after 4, 8, and 12 weeks. Ten patients (11.1%) were found to have recovered their sense of smell after one month, while 5 patients (5.56%) recovered within 2 months, and 1 patient (1.11%) recovered in 3 months. Conclusion: Complete recovery was noted in 73% of the patients within a period of 2 weeks, whereas persistence of symptoms was noted in 6 patients (6.67%) after 3 months.\",\"PeriodicalId\":42380,\"journal\":{\"name\":\"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2022-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15557/pimr.2022.0036\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatria i Medycyna Rodzinna-Paediatrics and Family Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15557/pimr.2022.0036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

目的:该研究的目的是概述马来西亚一个三级中心2019冠状病毒病(新冠肺炎)患者嗅觉功能障碍的纵向结果。材料和方法:本研究招募了通过逆转录聚合酶链反应检测出新冠肺炎呈阳性并入住马来西亚Sungai Buloh医院的成年患者。患者通过电话访谈完成了一份问卷,包括以下细节:年龄、性别、种族、合并症、一般和耳鼻喉科症状,以及嗅觉和味觉功能障碍的发作和持续时间。初次访谈时持续嗅觉和味觉功能障碍的患者每3至5天进行一次随访,直到病情好转。结果:在378名接触的患者中,共有185名患者被纳入本研究。90名患者报告了嗅觉功能障碍症状,其中59人抱怨嗅觉缺失。参与者的平均年龄为39.52岁(年龄范围:18-66岁)。超过一半的嗅觉功能障碍患者没有合并症(55.56%)。在90名嗅觉功能障碍患者中,66名患者(73.3%)在2周内完全恢复了嗅觉功能,其中包括40名男性和26名女性。其余24名患者在4、8和12周后进行了接触。10名患者(11.1%)在一个月后恢复了嗅觉,5名患者(5.56%)在2个月内恢复,1名患者(1.11%)在3个月内康复。结论:73%的患者在2周内完全康复,而6名患者(6.67%)在3个月后症状持续。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Longitudinal study of olfactory dysfunction among COVID-19 patients in a single tertiary centre in Malaysia
Aim: The aim of the study was to outline the longitudinal outcomes of olfactory dysfunction amongst patients with coronavirus disease 2019 (COVID-19) in a single tertiary centre in Malaysia. Materials and methods: Adults patients who tested positive for COVID-19 via reverse transcription-polymerase chain reaction and were admitted to Hospital Sungai Buloh, Malaysia, were recruited in this study. The patients completed a questionnaire via telephone interview comprising the following details: age, sex, ethnicity, comorbidities, general and otorhinolaryngological symptoms, and onset and duration of olfactory and gustatory dysfunction. The patients with persistent olfactory and gustatory dysfunction at the time of the initial interview were followed up every 3 to 5 days until resolution. Results: A total 185 patients were included in this study out of 378 patients contacted. Ninety patients reported olfactory dysfunction symptoms, with 59 of them complaining of anosmia. The mean age of the participants was 39.52 years (age range: 18–66 years). More than half of the patients with olfactory dysfunction had no comorbidities (55.56%). Of the 90 patients with olfactory dysfunction, 66 patients (73.3%), including 40 males and 26 females, regained their olfactory function completely within 2 weeks. The remaining 24 patients were contacted after 4, 8, and 12 weeks. Ten patients (11.1%) were found to have recovered their sense of smell after one month, while 5 patients (5.56%) recovered within 2 months, and 1 patient (1.11%) recovered in 3 months. Conclusion: Complete recovery was noted in 73% of the patients within a period of 2 weeks, whereas persistence of symptoms was noted in 6 patients (6.67%) after 3 months.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
33
审稿时长
20 weeks
期刊介绍: PEDIATRIA I MEDYCYNA RODZINNA is a peer-reviewed scientific journal publishing original articles that constitute significant contributions to the advancements of paediatrics and family medicine. In addition, PEDIATRIA I MEDYCYNA RODZINNA, publishes information from the medical associations, reports and materials from international congresses, letters to the Editor, information on new medical products as well as abstracts and discussions on papers published in other scientific journals, reviews of books and other publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信